This is the authors' abstract. We don't add key points for this paper.
binding assay based on FRET measurements, which showed that EC23 was a strongly binding, pan-agonist of the RARs, while EC19 exhibited specificity for RARβ, as predicted by the docking studies. These findings can account for the distinct behaviour of EC23 and EC19 in cellular differentiation assays, and additionally, the methods described herein can be further applied to the understanding of the molecular basis for the selectivity of different retinoids to RARα, β and γ.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Haffez et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: